These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1222507)

  • 1. Urinary excretion of monoamines and their metabolites in patients with Parkinson's disease. Response to long-term treatment with levodopa alone or in combination with a dopa decarboxylase inhibitor and clinical correlations.
    Siirtola T; Sonninen V; Rinne UK
    Clin Neurol Neurosurg; 1975; 78(2):77-88. PubMed ID: 1222507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary monoamine metabolite excretion in disorders of movement. Effects of amantadine and levodopa.
    Lenman JA; Turnbull MJ; Reid A; Fleming AM
    J Neurol Sci; 1977 Jun; 32(2):219-25. PubMed ID: 874521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of clinical symptoms, HVA and 5-HIAA in csf and plasma L-DOPA in Parkinsonian patients treated with L-DOPA and L-DOPA + RO 4-4602.
    Campanella G; Algeri S; Cerletti C; Dolfini E; Jori A; Rinaldi F
    Eur J Clin Pharmacol; 1977 Apr; 11(4):255-61. PubMed ID: 862646
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduced urinary excretion of dopamine and metabolites in chronic renal parenchymal disease.
    Pestana M; Jardim H; Serrão P; Soares-da-Silva P; Guerra L
    Kidney Blood Press Res; 1998; 21(1):59-65. PubMed ID: 9661138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-deprenyl treatment of on-off phenomena in Parkinson's disease.
    Rinne UK; Siirtola T; Sonninen V
    J Neural Transm; 1978; 43(3-4):253-62. PubMed ID: 745018
    [No Abstract]   [Full Text] [Related]  

  • 6. Day-to-day intraindividual reliability and interindividual differences in monoamines excretion.
    Curtin F; Walker JP; Schulz P
    J Affect Disord; 1996 Jun; 38(2-3):173-8. PubMed ID: 8791186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetrahydrobiopterin and Parkinson's disease.
    Dissing IC; Güttler F; Pakkenberg H; Lou H; Gerdes AM; Lykkelund C; Rasmussen V
    Acta Neurol Scand; 1989 Jun; 79(6):493-9. PubMed ID: 2476906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease: the effect of L-dopa therapy on urinary free catecholamines and metabolites.
    Davidson DF; Grosset K; Grosset D
    Ann Clin Biochem; 2007 Jul; 44(Pt 4):364-8. PubMed ID: 17594783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary noradrenaline and serotonin metabolites in drug-free Parkinson patients and the effect of L-dopa treatment.
    Markianos M; Hadjikonstantinou M; Bistolaki E
    Acta Neurol Scand; 1982 Aug; 66(2):267-75. PubMed ID: 6182730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biogenic amine/metabolite response during in-flight emergencies.
    Krahenbuhl GS; Harris J; Malchow RD; Stern JR
    Aviat Space Environ Med; 1985 Jun; 56(6):576-80. PubMed ID: 2409957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamines and their metabolites in plasma and lumbar cerebrospinal fluid of Chinese patients with Parkinson's disease.
    Chia LG; Cheng FC; Kuo JS
    J Neurol Sci; 1993 Jun; 116(2):125-34. PubMed ID: 8336158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of R-(-)-deprenyl in de novo parkinsonian patients pretreated with levodopa and decarboxylase inhibitor correlated to depression and MHPG, HIAA and HVA levels in the cerebrospinal fluid.
    Przuntek H; Kuhn W; Kraus P
    Acta Neurol Scand Suppl; 1989; 126():153-6. PubMed ID: 2482649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine.
    Eisenhofer G; Brown S; Peitzsch M; Pelzel D; Lattke P; Glöckner S; Stell A; Prejbisz A; Fassnacht M; Beuschlein F; Januszewicz A; Siegert G; Reichmann H
    Ann Clin Biochem; 2014 Jan; 51(Pt 1):38-46. PubMed ID: 23873873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of studies on the treatment of parkinsonian syndromes with levodopa. II. Long-term effects of L-DOPA alone or in combination with a decarboxylase inhibitor].
    Rabadeau Dumas JL; Rondot P; Cardon P
    Therapie; 1977; 32(2):161-72. PubMed ID: 898124
    [No Abstract]   [Full Text] [Related]  

  • 15. [Determination of four biogenic amine metabolites in urine by high-performance liquid chromatography].
    Jiang K; Wu H; Qin W; Gu G; Yu S
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2014 Feb; 32(2):140-2. PubMed ID: 24630022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Niacin depletion in Parkinsonian patients treated with L-dopa, benserazide and carbidopa.
    Bender DA; Earl CJ; Lees AJ
    Clin Sci (Lond); 1979 Jan; 56(1):89-93. PubMed ID: 477187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary levels of biogenic amine metabolites in mentally retarded children.
    Nalini K; Aroor AR; Rao A
    J Ment Defic Res; 1988 Oct; 32 ( Pt 5)():419-24. PubMed ID: 2462053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled-release levodopa/benserazide (Madopar HBS): clinical observations and levodopa and dopamine plasma concentrations in fluctuating parkinsonian patients.
    Ceballos-Baumann AO; von Kummer R; Eckert W; Weicker H
    J Neurol; 1990 Feb; 237(1):24-8. PubMed ID: 2181074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic adrenergic changes during submaximal exercise and in the recovery period in man.
    Pequignot JM; Peyrin L; Mayet MH; Flandrois R
    J Appl Physiol Respir Environ Exerc Physiol; 1979 Oct; 47(4):701-5. PubMed ID: 511676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment of Parkinson's disease with L-Dopa and Dopa-decarboxylase inhibitor: therapeutic results and side effects.
    Battistin L; Meneghetti G; Rigotti S; Saia A
    Acta Neurol Scand; 1978 Feb; 57(2):186-92. PubMed ID: 347868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.